Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2'-nor-cyclic GMP on adenovirus replication in vitro
Open Access
- 1 February 1987
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (2) , 337-339
- https://doi.org/10.1128/aac.31.2.337
Abstract
The inhibitory effects of 20 selected antiviral compounds on the replication of adenoviruses (types 1 to 8) in vitro were investigated. While 18 compounds were ineffective, 2 compounds, namely (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine [(S)-HPMPA] and 9-[(2-hydroxy-1,3,2-dioxaphosphorinan-5-yl)oxymethyl]guanine P-oxide (29-nor-cyclic GMP), were highly effective against all adenovirus types assayed in human embryonic fibroblast cultures. Their 50% inhibitory doses were 1.1 microgram/ml for (S)-HPMPA and 4.1 micrograms/ml for 29-nor-cyclic GMP. They were nontoxic for the host cells at the effective antiviral doses.This publication has 16 references indexed in Scilit:
- 2′-nor-cGMP: A seco-cyclic nucleotide with powerful anti-DNA-viral activityBiochemical and Biophysical Research Communications, 1985
- Adenovirus Infections in Patients Undergoing Bone-Marrow TransplantationNew England Journal of Medicine, 1985
- Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogsPharmacology & Therapeutics, 1984
- Antiviral activity of C-5 substituted tubercidin analogsJournal of Medicinal Chemistry, 1984
- Broad-spectrum antiviral activity of the carbocyclic analog of 3-deazaadenosineAntiviral Research, 1983
- Purification of an adenovirus-coded DNA polymerase that is required for initiation of DNA replicationCell, 1982
- Antiviral effects of phosphonoformate (PFA, foscarnet sodium)Pharmacology & Therapeutics, 1982
- ( S )-9-(2,3-Dihydroxypropyl)adenine: An Aliphatic Nucleoside Analog with Broad-Spectrum Antiviral ActivityScience, 1978
- Antiviral Activity of 3-Deazaguanine, 3-Deazaguanosine, and 3-Deazaguanylic AcidAntimicrobial Agents and Chemotherapy, 1977
- Broad-Spectrum Antiviral Activity of Virazole: 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamideScience, 1972